Skip to main content
Livermore
Livermore
ZHEN

Alps Advisors Inc

SEC CIK
0001376113
Latest filing
Jul 29, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of AKRO by Alps Advisors Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−37,356−100.0%Sold outHolders
Q3 202537,356$1.77M<0.1%−5,573−13.0%ReducedHolders
Q2 202542,929$2.29M<0.1%−15,376−26.4%ReducedHolders
Q1 202558,305$2.36M<0.1%+1,865+3.3%AddedHolders
Q4 202456,440$1.57M<0.1%+3,405+6.4%AddedHolders
Q3 202453,035$1.52M<0.1%−904−1.7%ReducedHolders
Q2 202453,939$1.27M<0.1%+14,230+35.8%AddedHolders
Q1 202439,709$1.00M<0.1%+2,477+6.7%AddedHolders
Q4 202337,232$869.4K<0.1%−3,776−9.2%ReducedHolders
Q3 202341,008$2.07M<0.1%+343+0.8%AddedHolders
Q2 202340,665$1.90M<0.1%+9,851+32.0%AddedHolders
Q1 202330,814$1.18M<0.1%−911−2.9%ReducedHolders
Q4 202231,725$1.74M<0.1%+11,177+54.4%AddedHolders
Q3 202220,548$700.0K<0.1%−229−1.1%ReducedHolders
Q2 202220,777$196.0K<0.1%−15,207−42.3%ReducedHolders
Q1 202235,984$511.0K<0.1%−4,389−10.9%ReducedHolders
Q4 202140,373$854.0K<0.1%−2,356−5.5%ReducedHolders
Q3 202142,729$955.0K<0.1%−3,143−6.9%ReducedHolders
Q2 202145,872$1.14M<0.1%−16,942−27.0%ReducedHolders
Q1 202162,814$1.82M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.